Package 0574-1133-04

{"route": ["ORAL"], "spl_id": "902035fb-dba8-4fdf-9d8d-29d736c07d57", "openfda": {"nui": ["N0000175557", "N0000011310"], "unii": ["27O7W4T232"], "rxcui": ["104232"], "spl_set_id": ["522bd365-ddcc-48f4-8a98-66dc4c3bb314"], "pharm_class_epc": ["Aldosterone Antagonist [EPC]"], "pharm_class_moa": ["Aldosterone Antagonists [MoA]"], "manufacturer_name": ["Padagis US LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "118 mL in 1 BOTTLE (0574-1133-04)", "package_ndc": "0574-1133-04", "marketing_start_date": "20231031"}, {"sample": false, "description": "10 CUP, UNIT-DOSE in 1 CARTON (0574-1133-10)  / 5 mL in 1 CUP, UNIT-DOSE (0574-1133-05)", "package_ndc": "0574-1133-10", "marketing_start_date": "20231031"}, {"sample": false, "description": "473 mL in 1 BOTTLE (0574-1133-16)", "package_ndc": "0574-1133-16", "marketing_start_date": "20231031"}], "brand_name": "SPIRONOLACTONE", "product_id": "0574-1133_902035fb-dba8-4fdf-9d8d-29d736c07d57", "dosage_form": "SUSPENSION", "pharm_class": ["Aldosterone Antagonist [EPC]", "Aldosterone Antagonists [MoA]"], "product_ndc": "0574-1133", "generic_name": "spironolactone", "labeler_name": "Padagis US LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "SPIRONOLACTONE", "active_ingredients": [{"name": "SPIRONOLACTONE", "strength": "25 mg/5mL"}], "application_number": "NDA209478", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_start_date": "20231031", "listing_expiration_date": "20261231"}